Effect of Subcutaneous Anti-CD20 Antibody-Mediated B Cell Depletion on Susceptibility to Pneumocystis Infection in Mice

Effect of Subcutaneous Anti-CD20 Antibody-Mediated B Cell Depletion on Susceptibility to Pneumocystis Infection in Mice

Anti-CD20 antibody therapy is used for both cancer and autoimmune disease but has been shown to be associated with PneumocystisPneumocystis

Bibliographic Details
Main Authors:	Guixiang Dai, Kristin Noell, Gisbert Weckbecker, Jay K. Kolls
Format:	Article
Language:	English
Published:	American Society for Microbiology 2021-06-01
Series:	mSphere
Online Access:	https://journals.asm.org/doi/10.1128/mSphere.01144-20

Similar Items

Toward a humanized mouse model of Pneumocystis pneumonia
by: Guixiang Dai, et al.
Published: (2021-01-01)

Efficient Distribution of a Novel Zirconium-89 Labeled Anti-cd20 Antibody Following Subcutaneous and Intravenous Administration in Control and Experimental Autoimmune Encephalomyelitis-Variant Mice
by: Mary-Anne Migotto, et al.
Published: (2019-10-01)

Unexpected and persistent depletion of B lymphocytes CD20 following a minimum dose of anti-CD20 antibody (Rituximab)
by: V. Bruzzese, et al.
Published: (2011-06-01)

Subcutaneous versus intravenous administration of rituximab: pharmacokinetics, CD20 target coverage and B-cell depletion in cynomolgus monkeys.
by: Cheng-Ping Mao, et al.
Published: (2013-01-01)

Antibody Response to Pneumocystis jirovecii
by: Kieran R. Daly, et al.
Published: (2006-08-01)

Mechanisms of action of non-depleting anti-CD4 monoclonal antibodies
by: Fehérvári, Zoltán Tamás
Published: (2000)

Discordant antibody and cellular responses to <it>Pneumocystis</it> major surface glycoprotein variants in mice
by: Bishop Lisa R, et al.
Published: (2012-07-01)

Non-depleting anti-CD4 antibody induced T regulatory cells inhibit asthmatic responses in OVA-sensitized mice
by: Chuang Chih-Hung, et al.
Published: (2005)

A protracted course of Pneumocystis pneumonia in the setting of an immunosuppressed child with GMS-negative bronchoalveolar lavage
by: Taylor Eddens, et al.
Published: (2016-03-01)

Anti-CD25 treatment depletes Treg cells and decreases disease severity in susceptible and resistant mice infected with Paracoccidioides brasiliensis.
by: Maíra Felonato, et al.
Published: (2012-01-01)

Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study.
by: Øystein Fluge, et al.
Published: (2011-01-01)

Clinical impact of B-cell depletion with the anti-CD20 antibody rituximab in chronic fatigue syndrome: a preliminary case series
by: Mella Olav, et al.
Published: (2009-07-01)

Anti-CD20-Mediated B Cell Depletion Is Associated With Bone Preservation in Lymphoma Patients and Bone Mass Increase in Mice
by: Albert Kolomansky, et al.
Published: (2020-10-01)

Transcriptomic and Proteomic Approaches to Finding Novel Diagnostic and Immunogenic Candidates in Pneumocystis
by: Taylor Eddens, et al.
Published: (2019-09-01)

Mass-Production and Characterization of Anti-CD20 Monoclonal Antibody in Peritoneum of Balb/c Mice
by: Leili Aghebati, et al.
Published: (2013-02-01)

Anti-CD20 B-cell depletion enhances monocyte reactivity in neuroimmunological disorders
by: Hohlfeld Reinhard, et al.
Published: (2011-10-01)

Ocrelizumab Depletes CD20+ T Cells in Multiple Sclerosis Patients
by: Stefan Gingele, et al.
Published: (2018-12-01)

Combined treatment with HMGN1 and anti-CD4 depleting antibody reverses T cell exhaustion and exerts robust anti-tumor effects in mice
by: Chang-Yu Chen, et al.
Published: (2019-01-01)

Anti-CD8 monoclonal antibody-mediated depletion alters the phenotype and behavior of surviving CD8+ T cells.
by: Eric W Cross, et al.
Published: (2019-01-01)

Anti-drug Antibodies Against a Novel Humanized Anti-CD20 Antibody Impair Its Therapeutic Effect on Primary Biliary Cholangitis in Human CD20- and FcγR-Expressing Mice
by: Yuki Moritoki, et al.
Published: (2018-11-01)

Relationship of Pneumocystis antibody responses to paediatric asthma severity
by: Alfin Vicencio, et al.
Published: (2021-08-01)

Surface levels of CD20 determine anti-CD20 antibodies mediated cell death in vitro.
by: Vijay Singh, et al.
Published: (2014-01-01)

A case of spontaneous pneumothorax, pneumomediastinum & subcutaneous emphysema in Pneumocystis jirovecii pneumonia complicating HIV
by: S Chatterji, et al.
Published: (2015-04-01)

Serum BAFF and APRIL Levels, T-Lymphocyte Subsets, and Immunoglobulins after B-Cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Myalgic Encephalopathy/Chronic Fatigue Syndrome.
by: Sigrid Lunde, et al.
Published: (2016-01-01)

Enhanced efficacy of gemcitabine in combination with anti-CD20 monoclonal antibody against CD20+ non-Hodgkin's lymphoma cell lines <it>in vitro </it>and in <it>scid </it>mice
by: Jin Fang, et al.
Published: (2005-08-01)

Transient B-cell depletion with anti-CD20 in combination with proinsulin DNA vaccine or oral insulin: immunologic effects and efficacy in NOD mice.
by: Ghanashyam Sarikonda, et al.
Published: (2013-01-01)

Ofatumumab: a novel monoclonal anti-CD20 antibody
by: Thomas S Lin
Published: (2010-05-01)

Neuropsychological deficits in mice depleted of the schizophrenia susceptibility gene CSMD1.
by: Vidar M Steen, et al.
Published: (2013-01-01)

Antigenic modulation limits the efficacy of anti-CD20 antibodies: implications for antibody selection
by: Beers, Stephen A., et al.
Published: (2010)

Pneumocystis jirovecii-related spontaneous pneumothorax, pneumomediastinum and subcutaneous emphysema in a liver transplant recipient: a case report
by: Wong Hoi She, et al.
Published: (2019-01-01)

Anti-CD22/CD20 Bispecific antibody with enhanced trogocytosis for treatment of Lupus.
by: Edmund A Rossi, et al.
Published: (2014-01-01)

A Depleting Anti-CD45 Monoclonal Antibody as Isolated Conditioning for Bone Marrow Transplantation in the Rat.
by: Mark D Jäger, et al.
Published: (2016-01-01)

NK cell depletion and recovery in SCID mice treated with anti-NK1.1 antibody.
by: Jerzy Kawiak, et al.
Published: (2006-06-01)

Production and Characterization of New Anti-Human CD20 Monoclonal Antibody
by: Mahdi Fasihi-Ramandi, et al.
Published: (2015-10-01)

Application of anti-CD20 monoclonal antibodies in the treatment of lymphoproliferative diseases
by: Pejčić Ivica, et al.
Published: (2009-01-01)

Clinical and translational research in Pneumocystis and Pneumocystis pneumonia*
by: Huang L.
Published: (2011-02-01)

B cell depletion with anti-CD20 mAb exacerbates anti-donor CD4+ T cell responses in highly sensitized transplant recipients
by: Asuka Tanaka, et al.
Published: (2021-09-01)

Depletion of CD4 and CD8 Positive T Cells Impairs Venous Thrombus Resolution in Mice
by: Subhradip Mukhopadhyay, et al.
Published: (2020-02-01)

COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma
by: Erik Gaitzsch, et al.
Published: (2021-07-01)

Echinocandin treatment of pneumocystis pneumonia in rodent models depletes cysts leaving trophic burdens that cannot transmit the infection.
by: Melanie T Cushion, et al.
Published: (2010-01-01)